Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03936556 · ClinicalTrials.gov registry record · Phase 4
A Clinical Study to Assess the Effects of a Stannous Fluoride Dentifrice on Plaque and Gingivitis
A Phase 4 study, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
NCT03936556 is a Phase 4 study that has completed, run by Procter and Gamble. The registered enrollment target is 84 participants.
The verdict
NCT03936556, a Phase 4 study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
Study Summary
The objective of this clinical study is to assess the effects of a 0.454% stannous fluoride dentifrice on gingivitis and plaque after 3 months when compared to a negative control.
Interventions
- DRUG Marketed Cavity Protection Toothpaste
- DRUG Marketed toothpaste
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2018-02-25 |
| Est. Completion | 2018-06-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03936556
The ClinicalTrials.gov registry entry for NCT03936556 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Marketed Cavity Protection Toothpaste is the first listed.
NCT03936556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03936556 about?
NCT03936556 is a clinical study titled "A Clinical Study to Assess the Effects of a Stannous Fluoride Dentifrice on Plaque and Gingivitis". The objective of this clinical study is to assess the effects of a 0.454% stannous fluoride dentifrice on gingivitis and plaque after 3 months when compared to a negative control.
What is the current status of trial NCT03936556?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2018-02-25. Estimated completion is 2018-06-03.
What interventions are being tested in trial NCT03936556?
The interventions under investigation include: Marketed Cavity Protection Toothpaste (DRUG), Marketed toothpaste (DRUG).
Who is sponsoring clinical trial NCT03936556?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.